Severe parechovirus infection in Norwegian infants

Pediatric Infectious Disease Journal

Volumn 33, Issue 12, 2014, Pages 1222-1225

  Skram, Marius K ^a   Skanke, Lars H ^b   Krokstad, Sidsel ^c   Nordbø, Svein A ^b,c   Nietsch, Lutz ^d   Døllner, Henrik ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d Alesund Hospital   (Norway)

Author keywords

Children; Encephalitis; Human parechovirus; Meningitis; Meningoencephalitis; Neonatal sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; PROTEIN VP1; PROTEIN VP3; VIRUS RNA;

ABDOMINAL RADIOGRAPHY; ACUTE RESPIRATORY FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BRAIN EDEMA; BRONCHIOLITIS; CEREBROSPINAL FLUID; CHILDHOOD DISEASE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EPILEPTIC DISCHARGE; GENOTYPING TECHNIQUE; HEPATITIS; HUMAN; HUMAN PARECHOVIRUS GENOTYPE 3 INFECTION; INFANT; IRRITABILITY; LEUKOPENIA; LUMBAR PUNCTURE; LUNG INFILTRATE; MALE; MENINGOENCEPHALITIS; METEORISM; NASOPHARYNGEAL ASPIRATION; NEUROIMAGING; NEUTROPENIA; NORWEGIAN (PEOPLE); NUCLEAR MAGNETIC RESONANCE IMAGING; PARECHOVIRUS; PHYLOGENY; PNEUMONIA; PRIORITY JOURNAL; RHINOVIRUS; RNA VIRUS INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; THORAX RADIOGRAPHY; TONIC CLONIC SEIZURE; VIRUS DETECTION; VIRUS STRAIN; CLASSIFICATION; CLUSTER ANALYSIS; FEMALE; GENETICS; GENOTYPE; HOSPITAL; ISOLATION AND PURIFICATION; NEWBORN; NORWAY; PATHOLOGY; PICORNAVIRIDAE INFECTIONS; SEPSIS; TREATMENT OUTCOME; VIROLOGY;

CLUSTER ANALYSIS; FEMALE; GENOTYPE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOENCEPHALITIS; NORWAY; PARECHOVIRUS; PHYLOGENY; PICORNAVIRIDAE INFECTIONS; RNA, VIRAL; SEPSIS; TREATMENT OUTCOME;

EID: 84926223609     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000456     Document Type: Article

References (25)

1. PSG Proposal, Human parechovirus. Available at: http://www.picornastudygroup. com/types/parechovirus/hpev. htm. Accessed September 13, 2014.
2. Ito M, Yamashita T, Tsuzuki H, et al. Isolation and identification of a novel human parechovirus. J Gen Virol. 2004;85(pt 2):391-398.
3. Bangalore H, Ahmed J, Bible J, et al. Abdominal distension: an important feature in human parechovirus infection. Pediatr Infect Dis J. 2011;30:260-262.
4. Benschop KS, Schinkel J, Minnaar RP, et al. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis. 2006;42:204-210.
5. Harvala H, McLeish N, Kondracka J, et al. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in Edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol. 2011;83:889-896.
6. Schuffenecker I, Javouhey E, Gillet Y, et al. Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. J Clin Virol. 2012;54:337-341.
7. Selvarangan R, Nzabi M, Selvaraju SB, et al. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J. 2011;30:238-242.
8. Sharp J, Harrison CJ, Puckett K, et al. Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J. 2013;32:213-216.
9. Verboon-Maciolek MA, Krediet TG, Gerards LJ, et al. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J. 2008;27:241-245.
10. Sedmak G, Nix WA, Jentzen J, et al. Infant deaths associated with human parechovirus infection in Wisconsin. Clin Infect Dis. 2010;50:357-361.
11. van Zwol AL, Lequin M, Aarts-Tesselaar C, et al. Fatal neonatal parechovirus encephalitis. BMJ Case Rep. 2009;2009.
12. Gupta S, Fernandez D, Siddiqui A, et al. Extensive white matter abnormalities associated with neonatal Parechovirus (HPeV) infection. Eur J Paediatr Neurol. 2010;14:531-534.
13. Verboon-Maciolek MA, Groenendaal F, Hahn CD, et al. Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol. 2008;64:266-273.
14. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
15. Nix WA, Maher K, Pallansch MA, et al. Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing. J Clin Virol. 2010;48:202-207.
16. Abed Y, Boivin G. Molecular characterization of a Canadian human parechovirus (HPeV)-3 isolate and its relationship to other HPeVs. J Med Virol. 2005;77:566-570.
17. Benschop KS, de Vries M, Minnaar RP, et al. Comprehensive full-length sequence analyses of human parechoviruses: diversity and recombination. J Gen Virol. 2010;91(pt 1):145-154.
18. Mizuta K, Kuroda M, Kurimura M, et al. Epidemic myalgia in adults associated with human parechovirus type 3 infection, Yamagata, Japan, 2008. Emerg Infect Dis. 2012;18:1787-1793.
19. van der Sanden S, de Bruin E, Vennema H, et al. Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J Clin Microbiol. 2008;46:2884-2889.
20. Yamamoto M, Abe K, Kuniyori K, et al. Epidemic of human parechovirus type 3 in Hiroshima city, Japan in 2008. Jpn J Infect Dis. 2009;62:244-245.
21. Felsenstein S, Yang S, Eubanks N, Sobrera E, Grimm JP, Aldrovandi G. Human parechovirus central nervous system infections in southern california children. Pediatr Infect Dis J. 2013;33:e87-e91.
22. Westerhuis B, Kolehmainen P, Benschop K, et al. Human parechovirus seroprevalence in Finland and the Netherlands. J Clin Virol. 2013;58:211-215.
23. Calvert J, Chieochansin T, Benschop KS, et al. Recombination dynamics of human parechoviruses: Investigation of type-specific differences in frequency and epidemiological correlates. J Gen Virol 2010, 23:224-230.
24. Westerhuis BM, Koen G, Wildenbeest JG, et al. Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development. J Gen Virol. 2012;93(pt 11):2363-2370.
25. Westerhuis BM, Jonker SC, Mattao S, et al. Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross-neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR. Virol J. 2013;10:146.